Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly total equity is $417,045 with QoQ Growth of (0.49%). Total equity, also called shareholders' equity, is assets minus liabilities. The book value in P/B is the part attributable to common shareholders: total equity minus preferred stock.
Reported quarterly total equity; no daily interpolation. Q2 FY2026 (2026-06-30): $417045.00.
FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock) Quote observation: 2026-10-06T19:35:43.726Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| Period | Total Equity | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $417,045 | (0.49%) | (78.03%) |
| Q1 FY2026Period end 2026-03-31 | $419,084 | (0.16%) | (99.32%) |
| Q4 FY2025Period end 2025-12-31 | $419,761 | (56.95%) | (99.32%) |
| Q3 FY2025Period end 2025-09-30 | $975,004 | (48.63%) | N/A |
| Q2 FY2025Period end 2025-06-30 | $1.90M | (96.94%) | N/A |
| Q1 FY2025Period end 2025-03-31 | $61.97M | +0.67% | N/A |
| Q4 FY2024Period end 2024-12-31 | $61.56M | N/A | N/A |
| Q3 FY2024Period end 2024-09-30 | ($187,354) | N/A | N/A |
| Q2 FY2024Period end 2024-06-30 | ($148,576) | N/A | N/A |
| Q4 FY2023Period end 2023-12-31 | ($140,576) | N/A | N/A |
| Q2 FY2022Period end 2022-06-30 | ($8.66M) | N/A | N/A |
| Q1 FY2022Period end 2022-03-31 | $209.47M | N/A | +4089.45% |
| Q4 FY2021Period end 2021-12-31 | ($24) | N/A | N/A |
| Q3 FY2021Period end 2021-09-30 | $212.65M | +2.44% | N/A |
| Q2 FY2021Period end 2021-06-30 | $207.59M | +4051.81% | N/A |
| Q1 FY2021Period end 2021-03-31 | $5.00M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.